Bayer Launches 'Grants4Apps Shanghai 2017' to Partner with Chinese Health Tech Startups
With 750 manufacturing plants across 200 locations on six continents, the company employs 120,000 people worldwide and operates 350 branches. Its product portfolio comprises more than 10,000 items, including aspirin, often hailed as the “Drug of the Century.” Well-known brands under its umbrella include Coppertone, Baijiahei, Kangwang, Talcid, Elevit, Claritin, Elocon, Canesten, Redoxon, and Coppertone—this is Bayer, Germany’s largest industrial conglomerate and a perennial member of the Fortune Global 500.
This year, their “Bayer Grants4Apps Shanghai 2017” is once again teaming up with startups in China’s healthcare sector. Of course, beyond just engaging with these entrepreneurs, they aim to identify partners capable of helping them address specific challenges, negotiate substantial deals with them, and simply ask: are you in?
On July 3, 2017, Bayer’s second round of open innovation initiative in China, Grants4Apps—“Bayer Start-up Program Shanghai 2017”—was officially launched, with VCBeat deeply involved and jointly promoting the effort. To date, there has been much speculation surrounding this project:
How does this year's project differ from last year's?
Why Do Experts Bring Newbies Along to Play?
What support does Bayer actually provide to startups?
Must companies seeking to collaborate with Bayer have completed their Series B financing round?
……
No matter what questions you may have, they will be answered in the VB group interview this Thursday at 8 p.m.!
July 13, 2017 (This Thursday at 8:00 PM)Bayer Co-hosts Interview with VCBeat VB GroupOnline Launch Event of Grants4Apps “Bayer Startup Program Shanghai 2017”, specific details of the program and the benefits offered to participating enterprises will be announced in due course.
Can’t wait? Simply scan the QR code below to register and join!
Lin Kai serves as Project Director at Bayer China, driving the company’s innovation initiatives in China and actively building bridges between Bayer and external innovative companies. Previously, Lin Kai was an internal consultant for Bayer Asia-Pacific, where he assisted business units in formulating strategic plans, developing product launch strategies, and implementing organizational restructuring.
Vivian Hartmann served as the overall lead for the planning and execution of Bayer China’s first startup incubator program in 2016. She spearheaded the entire process, including architectural planning, partner recruitment, startup selection, event organization, and corporate training, while establishing close ties with China’s startup ecosystem, potential investors, and media to jointly support the group’s growth and development. Previously, she led her own startup to participate in Bayer’s “Grants4Apps” incubator program in Berlin in 2015.